Journal
PHARMACOLOGICAL RESEARCH
Volume 145, Issue -, Pages -Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2019.104254
Keywords
15,16-Dihydrotanshinone I; Anti-cancer; Cardiovascular protection; Anti-inflammation; Hypoxia-inducible factor; Human antigen R
Categories
Funding
- Science and Technology Development Fund, Macao S.A.R (FDCT) [078/2016/A2]
- University of Macau [MYRG201600043-ICMS-QRCM]
- National Natural Science Foundation of China (NSFC) [81774200]
Ask authors/readers for more resources
Salvia miltiorrhiza Bunge (Danshen), a famous traditional Chinese herb, has been used clinically for the treatment of various diseases for centuries. Document data showed that tanshinones, a class of lipophilic abietane diterpenes rich in this herb, possess multiple biological effects in vitro and in vivo models. Among which, 15,16-dihydrotanshinone I (DHT) has received much attention in recent years. In this systematical review, we carefully selected, analyzed, and summarized high-quality publications related to pharmacological effects and the underlying mechanisms of DHT. DHT has anti-cancer, cardiovascular protective, anti-inflammation, anti Alzheimer's disease, and other effects. Furthermore, several molecules such as hypoxia-inducible factor (HIF-1 alpha), human antigen R (HuR), acetylcholinesterase (AchE), etc. have been identified as the potential targets for DHT. The diverse pharmacological activities of DHT provide scientific evidence for the local and traditional uses of Salvia miltiorrhiza Bunge. We concluded that DHT might serve as a lead compound for drug discovery in related diseases while further in-depth investigations are still needed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available